 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Labatec-Pharma S.A. |
| Street 1: | 31, Rue du Cardinal-Journet |
| Street 2: | |
| City: | Geneve |
| Province: | |
| Post Code: | |
| Country: | Switzerland |
| Phone: | 0041225937821 |
| Email: | julia.engelking@labatec.ch |
| Web Site: | http://www.labatec.ch |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | None |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | International |
| Organization Description: | |
| Labatec Pharma is a Swiss pharmaceuticals company based in Geneva backed by more than 50 years’ experience in proposing high-quality products. Labatec The contribution of Labatec Labatec: a reliable partner for treating Tuberculosis With a strong portfolio of current and underdevelopment anti-tuberculosis drugs, we are committed to supply critical medication for this disease worldwide. Currently Myambutol 100mg and 400mg (Ethambutol), Rifampicine 150mg and 300mg, are under assessment by the World Health Organisation for Prequalification. Most of our products are listed on the Global Fund Anti TB list of Pharmaceutical Suppliers. Labatec provides Swiss Hospitals and Patients with: •Isoniazid 100 mg & 300 mg Labatec has a renewable import market authorisation from Swissmedic for Isoniazid 100mg (tablets). Isoniazid is registered and manufactured in the USA in FDA approved facilities. We currently have stock to cover the full needs of all Swiss hospitals and pharmacies. Starting in March 2012, Isoniazid has been integrated into the Reimbursement List of Specialties in Switzerland. •Ethambutol 100 and 400 mg •Rifampicine 150 and 300 mg •Pyrazinamide 500 mg The remaining three molecules are manufactured in our Geneva Switzerland facilities. |
|
| Total number of staff in your organization: | 26 - 50 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 0 |
| What is your organization's annual budget (USD) dedicated to TB? | Unable to disclose amount |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Labatec provides Swiss Hospitals and Patients with: •Isoniazid 100 mg & 300 mg |
|
Geographical Reach | |
| Which country is your headquarters located in: | Switzerland |
| Which WHO region is the main focus of your work: | South East Asian |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Afghanistan Albania Algeria Andorra Angola Antigua and Barbuda Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Central African Republic Chad Chile China Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Democratic Republic of Timor-Leste Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Greece Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Lithuania Luxembourg Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Mongolia Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Zealand Nicaragua Niger Nigeria Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Qatar Republic of Korea Republic of Moldova Republic of Montenegro Republic of Serbia Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan Suriname Swaziland Sweden Switzerland Syrian Arab Republic Tajikistan Thailand The Former Yugoslav Rep of Macedonia Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United Republic of Tanzania United States of America Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Yemen Zambia Zimbabwe |
Specializations | |
|
Provision of drugs, diagnostics and commodities |
Specializations in Countries | |
| Provision of drugs, diagnostics and commodities | Afghanistan |
| Provision of drugs, diagnostics and commodities | Albania |
| Provision of drugs, diagnostics and commodities | Algeria |
| Provision of drugs, diagnostics and commodities | Andorra |
| Provision of drugs, diagnostics and commodities | Angola |
| Provision of drugs, diagnostics and commodities | Antigua and Barbuda |
| Provision of drugs, diagnostics and commodities | Argentina |
| Provision of drugs, diagnostics and commodities | Armenia |
| Provision of drugs, diagnostics and commodities | Australia |
| Provision of drugs, diagnostics and commodities | Austria |
| Provision of drugs, diagnostics and commodities | Azerbaijan |
| Provision of drugs, diagnostics and commodities | Bahamas |
| Provision of drugs, diagnostics and commodities | Bahrain |
| Provision of drugs, diagnostics and commodities | Bangladesh |
| Provision of drugs, diagnostics and commodities | Barbados |
| Provision of drugs, diagnostics and commodities | Belarus |
| Provision of drugs, diagnostics and commodities | Belgium |
| Provision of drugs, diagnostics and commodities | Belize |
| Provision of drugs, diagnostics and commodities | Benin |
| Provision of drugs, diagnostics and commodities | Bhutan |
| Provision of drugs, diagnostics and commodities | Bolivia |
| Provision of drugs, diagnostics and commodities | Bosnia and Herzegovina |
| Provision of drugs, diagnostics and commodities | Botswana |
| Provision of drugs, diagnostics and commodities | Brazil |
| Provision of drugs, diagnostics and commodities | Brunei Darussalam |
| Provision of drugs, diagnostics and commodities | Bulgaria |
| Provision of drugs, diagnostics and commodities | Burkina Faso |
| Provision of drugs, diagnostics and commodities | Burundi |
| Provision of drugs, diagnostics and commodities | Cambodia |
| Provision of drugs, diagnostics and commodities | Cameroon |
| Provision of drugs, diagnostics and commodities | Canada |
| Provision of drugs, diagnostics and commodities | Cape Verde |
| Provision of drugs, diagnostics and commodities | Central African Republic |
| Provision of drugs, diagnostics and commodities | Chad |
| Provision of drugs, diagnostics and commodities | Chile |
| Provision of drugs, diagnostics and commodities | China |
| Provision of drugs, diagnostics and commodities | Colombia |
| Provision of drugs, diagnostics and commodities | Comoros |
| Provision of drugs, diagnostics and commodities | Congo |
| Provision of drugs, diagnostics and commodities | Cook Islands |
| Provision of drugs, diagnostics and commodities | Costa Rica |
| Provision of drugs, diagnostics and commodities | Cote d'Ivoire |
| Provision of drugs, diagnostics and commodities | Croatia |
| Provision of drugs, diagnostics and commodities | Cuba |
| Provision of drugs, diagnostics and commodities | Cyprus |
| Provision of drugs, diagnostics and commodities | Czech Republic |
| Provision of drugs, diagnostics and commodities | Democratic People's Republic of Korea |
| Provision of drugs, diagnostics and commodities | Democratic Republic of the Congo |
| Provision of drugs, diagnostics and commodities | Democratic Republic of Timor-Leste |
| Provision of drugs, diagnostics and commodities | Denmark |
| Provision of drugs, diagnostics and commodities | Djibouti |
| Provision of drugs, diagnostics and commodities | Dominica |
| Provision of drugs, diagnostics and commodities | Dominican Republic |
| Provision of drugs, diagnostics and commodities | Ecuador |
| Provision of drugs, diagnostics and commodities | Egypt |
| Provision of drugs, diagnostics and commodities | El Salvador |
| Provision of drugs, diagnostics and commodities | Equatorial Guinea |
| Provision of drugs, diagnostics and commodities | Eritrea |
| Provision of drugs, diagnostics and commodities | Estonia |
| Provision of drugs, diagnostics and commodities | Ethiopia |
| Provision of drugs, diagnostics and commodities | Fiji |
| Provision of drugs, diagnostics and commodities | Finland |
| Provision of drugs, diagnostics and commodities | France |
| Provision of drugs, diagnostics and commodities | Gabon |
| Provision of drugs, diagnostics and commodities | Gambia |
| Provision of drugs, diagnostics and commodities | Georgia |
| Provision of drugs, diagnostics and commodities | Germany |
| Provision of drugs, diagnostics and commodities | Ghana |
| Provision of drugs, diagnostics and commodities | Greece |
| Provision of drugs, diagnostics and commodities | Grenada |
| Provision of drugs, diagnostics and commodities | Guatemala |
| Provision of drugs, diagnostics and commodities | Guinea |
| Provision of drugs, diagnostics and commodities | Guinea-Bissau |
| Provision of drugs, diagnostics and commodities | Guyana |
| Provision of drugs, diagnostics and commodities | Haiti |
| Provision of drugs, diagnostics and commodities | Honduras |
| Provision of drugs, diagnostics and commodities | Hungary |
| Provision of drugs, diagnostics and commodities | Iceland |
| Provision of drugs, diagnostics and commodities | India |
| Provision of drugs, diagnostics and commodities | Indonesia |
| Provision of drugs, diagnostics and commodities | Iran (Islamic Republic of) |
| Provision of drugs, diagnostics and commodities | Iraq |
| Provision of drugs, diagnostics and commodities | Ireland |
| Provision of drugs, diagnostics and commodities | Israel |
| Provision of drugs, diagnostics and commodities | Italy |
| Provision of drugs, diagnostics and commodities | Jamaica |
| Provision of drugs, diagnostics and commodities | Japan |
| Provision of drugs, diagnostics and commodities | Jordan |
| Provision of drugs, diagnostics and commodities | Kazakhstan |
| Provision of drugs, diagnostics and commodities | Kenya |
| Provision of drugs, diagnostics and commodities | Kiribati |
| Provision of drugs, diagnostics and commodities | Kuwait |
| Provision of drugs, diagnostics and commodities | Kyrgyzstan |
| Provision of drugs, diagnostics and commodities | Lao People's Democratic Republic |
| Provision of drugs, diagnostics and commodities | Latvia |
| Provision of drugs, diagnostics and commodities | Lebanon |
| Provision of drugs, diagnostics and commodities | Lesotho |
| Provision of drugs, diagnostics and commodities | Liberia |
| Provision of drugs, diagnostics and commodities | Libyan Arab Jamahiriya |
| Provision of drugs, diagnostics and commodities | Lithuania |
| Provision of drugs, diagnostics and commodities | Luxembourg |
| Provision of drugs, diagnostics and commodities | Madagascar |
| Provision of drugs, diagnostics and commodities | Malawi |
| Provision of drugs, diagnostics and commodities | Malaysia |
| Provision of drugs, diagnostics and commodities | Maldives |
| Provision of drugs, diagnostics and commodities | Mali |
| Provision of drugs, diagnostics and commodities | Malta |
| Provision of drugs, diagnostics and commodities | Marshall Islands |
| Provision of drugs, diagnostics and commodities | Mauritania |
| Provision of drugs, diagnostics and commodities | Mauritius |
| Provision of drugs, diagnostics and commodities | Mexico |
| Provision of drugs, diagnostics and commodities | Micronesia (Federated States of) |
| Provision of drugs, diagnostics and commodities | Monaco |
| Provision of drugs, diagnostics and commodities | Mongolia |
| Provision of drugs, diagnostics and commodities | Morocco |
| Provision of drugs, diagnostics and commodities | Mozambique |
| Provision of drugs, diagnostics and commodities | Myanmar |
| Provision of drugs, diagnostics and commodities | Namibia |
| Provision of drugs, diagnostics and commodities | Nauru |
| Provision of drugs, diagnostics and commodities | Nepal |
| Provision of drugs, diagnostics and commodities | Netherlands |
| Provision of drugs, diagnostics and commodities | New Zealand |
| Provision of drugs, diagnostics and commodities | Nicaragua |
| Provision of drugs, diagnostics and commodities | Niger |
| Provision of drugs, diagnostics and commodities | Nigeria |
| Provision of drugs, diagnostics and commodities | Niue |
| Provision of drugs, diagnostics and commodities | Norway |
| Provision of drugs, diagnostics and commodities | Oman |
| Provision of drugs, diagnostics and commodities | Pakistan |
| Provision of drugs, diagnostics and commodities | Palau |
| Provision of drugs, diagnostics and commodities | Panama |
| Provision of drugs, diagnostics and commodities | Papua New Guinea |
| Provision of drugs, diagnostics and commodities | Paraguay |
| Provision of drugs, diagnostics and commodities | Peru |
| Provision of drugs, diagnostics and commodities | Philippines |
| Provision of drugs, diagnostics and commodities | Poland |
| Provision of drugs, diagnostics and commodities | Portugal |
| Provision of drugs, diagnostics and commodities | Qatar |
| Provision of drugs, diagnostics and commodities | Republic of Korea |
| Provision of drugs, diagnostics and commodities | Republic of Moldova |
| Provision of drugs, diagnostics and commodities | Republic of Montenegro |
| Provision of drugs, diagnostics and commodities | Republic of Serbia |
| Provision of drugs, diagnostics and commodities | Romania |
| Provision of drugs, diagnostics and commodities | Russian Federation |
| Provision of drugs, diagnostics and commodities | Rwanda |
| Provision of drugs, diagnostics and commodities | Saint Kitts and Nevis |
| Provision of drugs, diagnostics and commodities | Saint Lucia |
| Provision of drugs, diagnostics and commodities | Saint Vincent and the Grenadines |
| Provision of drugs, diagnostics and commodities | Samoa |
| Provision of drugs, diagnostics and commodities | San Marino |
| Provision of drugs, diagnostics and commodities | Sao Tome and Principe |
| Provision of drugs, diagnostics and commodities | Saudi Arabia |
| Provision of drugs, diagnostics and commodities | Senegal |
| Provision of drugs, diagnostics and commodities | Seychelles |
| Provision of drugs, diagnostics and commodities | Sierra Leone |
| Provision of drugs, diagnostics and commodities | Singapore |
| Provision of drugs, diagnostics and commodities | Slovakia |
| Provision of drugs, diagnostics and commodities | Slovenia |
| Provision of drugs, diagnostics and commodities | Solomon Islands |
| Provision of drugs, diagnostics and commodities | Somalia |
| Provision of drugs, diagnostics and commodities | South Africa |
| Provision of drugs, diagnostics and commodities | South Sudan |
| Provision of drugs, diagnostics and commodities | Spain |
| Provision of drugs, diagnostics and commodities | Sri Lanka |
| Provision of drugs, diagnostics and commodities | Sudan |
| Provision of drugs, diagnostics and commodities | Suriname |
| Provision of drugs, diagnostics and commodities | Swaziland |
| Provision of drugs, diagnostics and commodities | Sweden |
| Provision of drugs, diagnostics and commodities | Switzerland |
| Provision of drugs, diagnostics and commodities | Syrian Arab Republic |
| Provision of drugs, diagnostics and commodities | Tajikistan |
| Provision of drugs, diagnostics and commodities | Thailand |
| Provision of drugs, diagnostics and commodities | The Former Yugoslav Rep of Macedonia |
| Provision of drugs, diagnostics and commodities | Togo |
| Provision of drugs, diagnostics and commodities | Tonga |
| Provision of drugs, diagnostics and commodities | Trinidad and Tobago |
| Provision of drugs, diagnostics and commodities | Tunisia |
| Provision of drugs, diagnostics and commodities | Turkey |
| Provision of drugs, diagnostics and commodities | Turkmenistan |
| Provision of drugs, diagnostics and commodities | Tuvalu |
| Provision of drugs, diagnostics and commodities | Uganda |
| Provision of drugs, diagnostics and commodities | Ukraine |
| Provision of drugs, diagnostics and commodities | United Arab Emirates |
| Provision of drugs, diagnostics and commodities | United Kingdom of Great Britain and Northern Ireland |
| Provision of drugs, diagnostics and commodities | United Republic of Tanzania |
| Provision of drugs, diagnostics and commodities | United States of America |
| Provision of drugs, diagnostics and commodities | Uruguay |
| Provision of drugs, diagnostics and commodities | Uzbekistan |
| Provision of drugs, diagnostics and commodities | Vanuatu |
| Provision of drugs, diagnostics and commodities | Venezuela |
| Provision of drugs, diagnostics and commodities | Viet Nam |
| Provision of drugs, diagnostics and commodities | Yemen |
| Provision of drugs, diagnostics and commodities | Zambia |
| Provision of drugs, diagnostics and commodities | Zimbabwe |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
DOTS Expansion and Enhancement: work with MOH increasingly to educate on drug quality, high standard Drug-Resistant TB: development of MDR-TB drugs New TB Drugs: Develeopment of drug innovations |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | August 24, 2012 |
| Last updated: | September 12, 2012 |